Drugs / Bifidobacterium animalis subsp. lactis Bl-04
Bifidobacterium animalis subsp. lactis Bl-04
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02679807 Comparator | Feb 2016 → Apr 2018 | common cold | University of Virginia | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium animalis subsp. lactis Bl-04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02679807 ↗ |
| Known as | Bifidobacterium animalis ssp. lactis (Bl-04) | “Bifidobacterium animalis ssp. lactis (Bl-04)” PMID 34927036 ↗ Dec 2021 |
| Known as | Bifidobacterium lactis Bl-04 | “Bifidobacterium lactis Bl-04” NCT02679807 ↗ |
| Known as | Bl-04 | “Bifidobacterium lactis Bl-04” NCT02679807 ↗ |
| Modality | Other / unclassified | “a probiotic (Bl-04)” NCT02679807 ↗ |
| Route | Oral | “orally administered Bl-04” PMID 34927036 ↗ Dec 2021 |